Skip to content

Annual CD4 count monitoring may be sufficient for people doing well on HIV treatment

Newly adopted risk behaviours predict HIV infections in Portuguese gay men

High-dose rifampicin may shorten time to TB clearance

Martin Boeree presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Women in PrEP trial feared they would have to leave study if they reported low adherence

Opioid substitution treatment increases chances that people who inject drugs will have good adherence to HIV therapy

Global hepatitis B epidemic treatable at cost of just $36 per patient per year

Six in ten US HIV infections are transmitted by people who know they have HIV but are not in care

End-stage liver disease is a concern for people with HIV and hepatitis B or C co-infection

Ritonavir concentrations not correlated with lipid levels in people with HIV taking boosted atazanavir or boosted darunavir